Verona Pharma Plc Total Revenue

The latest total revenue for VRNA is $220M as of June 2025. That compares with $940K in the prior-year period — up 23480.8% year over year. That is below the Healthcare sector average of $110B. Investors often review this figure alongside Verona Pharma Plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, VRNA's total revenue moved from $940K to $220M — a 23480.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Verona Pharma Plc's operating scale or balance-sheet position.

Against Healthcare companies, VRNA currently prints $220M for total revenue, while the sector average sits near $110B. That is roughly 99.8% below the sector mean. Large gaps often invite a closer look at Verona Pharma Plc's growth, margins, and balance sheet.

A total revenue figure of $220M for VRNA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $110B. Explore the charts below for those layers of context.

After noting VRNA's total revenue ($220M), review year-over-year change from $940K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.